Daily Roundup

PGH.ASX GQG.ASX AHC.ASX REA.ASX MDR.ASX

Here is a news roundup covering the top announcements for the day:

Pact Group Faces Delisting Challenges
The Takeovers Panel has received an application regarding Pact Group Holdings' (ASX: PGH) proposed delisting from the ASX. The applicant claims the delisting process is unacceptable, citing concerns over low liquidity, a short window for shareholders to sell, and the potential for the major shareholder to consolidate ownership. The applicant is seeking various orders, including to stay the delisting and improve disclosure.

GQG Partners Maintains Dividend, Reports Strong FUM
GQG Partners Inc. (ASX: GQG) announced a quarterly dividend of US$0.0378 per share, representing 93.3% of the company's estimated first quarter distributable earnings. This is consistent with the final 2024 dividend amount. Additionally, GQG reported total funds under management (FUM) of $163.6 billion as at 30 April 2025, up from $161.9 billion the previous month, driven by $1.4 billion in net flows.

Austco Healthcare Secures Major US Contract Renewal
Austco Healthcare Limited (ASX: AHC) has renewed a preferred supplier agreement with one of the largest healthcare providers in the United States. Under the agreement, Austco will continue delivering its Tacera IP Nurse Call system and software platform to approximately 180 hospitals across the US. This builds on a previous 5-year agreement that generated over A$49 million in revenue for the company.

REA Group Delivers Stellar Q3 Result
REA Group Ltd (ASX: REA) reported a strong Q3 FY25 performance, with revenue up 18% to $1,247 million and EBITDA up 19% to $734 million. The company's flagship site realestate.com.au maintained its market-leading position, reaching record audiences during the quarter. Looking ahead, REA expects continued strong buyer demand and modest property price growth, supporting further yield expansion.

MedAdvisor Progresses Strategic Review with Potential ANZ Sale
MedAdvisor Limited (ASX: MDR) has provided an update on its strategic review, announcing it has entered a non-binding Letter of Intent to sell its ANZ business division to an Australian subsidiary of a prominent, multinational software company for a headline price of $35 million plus an uncapped earn-out of up to $7.35 million. The company has granted the potential buyer an exclusivity period to conduct due diligence.